AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COCHLEAR LTD

133.920

-2.180-1.60%

Volume:9.70M

Turnover:1.30B

Market Cap:8.76B

PE:59.57

High:135.670

Open:135.260

Low:132.330

Close:136.100

52wk High:297.775

52wk Low:88.740

Shares:65.40M

Float Shares:65.14M

Volume Ratio:22.24

T/O Rate:14.89%

Dividend:4.30

Dividend Rate:3.21%

EPS(TTM):2.248

EPS(LYR):2.248

ROE:7.98%

ROA:9.71%

PB:5.03

PE(LYR):59.57

Loading ...

Overview Company News Filings

Stock Track | Cochlear Ltd Plummets 33.74% Intraday on Earnings Guidance Cut and Middle East Sales Uncertainty

Cochlear Ltd - Sees Second Half Sales Growth of 2-6% in Constant Currency

THOMSON REUTERS

Cochlear Ltd-Trading Update and Reduction to FY26 Earnings Guidance

THOMSON REUTERS

Cochlear Ltd - There Is Heightened Uncertainty to Q4 Sales From Middle East Due to Conflict

THOMSON REUTERS

Cochlear Ltd - Accelerating Plans to ReShape Cost Base to Provide Increased Capacity to Invest in Growth

THOMSON REUTERS

Cochlear Ltd - Reduces Underlying Net Profit Guidance for FY26 to a$290-330 Mln

THOMSON REUTERS

Cochlear Ltd - May Need to Consider Provisioning Some Receivables Due to M.east Conflict, up to a$10 Million Potential Net Profit Impact

THOMSON REUTERS

Cochlear Ltd - Since January, Trading Conditions for Cochlear Implants in Developed Markets Have Been Softer Than Expected

THOMSON REUTERS

Cochlear Says Bank of New York Mellon Becomes Substantial Holder

MT Newswires Live

BUZZ-Australia's Cochlear enters recruiting phase for implant trial, Citi says

Three Dependable ASX Dividend Stocks for Passive Investment Strategies

Achieving Millionaire Status Through Annual $5,000 Investments in ASX 200 Stocks

The ASX healthcare stocks with the biggest upside according to brokers

Top brokers name 3 ASX shares to buy today

Cochlear Bulls See No Near-Term Gene Therapy Impact -- Market Talk

3 top blue-chip ASX 200 shares that look dirt cheap right now

I'm listening to Warren Buffett and loading up on cheap ASX shares

CSL and these ASX 200 stocks just hit 52-week lows: Should you buy the dip?

Why Cochlear and ResMed shares could be strong buys

Cochlear Poised for Medium-Term Growth on Nexa Launch, Jefferies Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/COH.AU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":133.92,"timestamp":1788156720000,"preClose":136.1,"halted":0,"volume":9698531,"delay":0,"changeRate":-0.016017634092579038,"nameEN":"COCHLEAR LTD","floatShares":65138365,"shares":65398462,"eps":2.248,"marketStatus":"Not Yet Opened","change":-2.18,"latestTime":"08-31 16:12:00 AEST","open":135.26,"high":135.67,"low":132.33,"amount":1298875575,"amplitude":0.024541,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.248,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":136.1,"dividendRate":0.0321,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":22.242990340857524,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COH.AU","preClose":133.92,"auctionPrice":132,"auctionVolume":2554,"auctionTime":1788215783744,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788215783744}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138365,"roa":"9.71%","roe":"7.98%","lyrEps":2.248,"volumeRatio":22.242990340857524,"shares":65398462,"dividePrice":4.2988,"high":135.67,"amplitude":0.024541,"preClose":136.1,"low":132.33,"week52Low":88.74,"pbRate":"5.03","psRate":"3.73","week52High":297.775,"institutionHeld":0,"latestPrice":133.92,"eps":2.248,"divideRate":0.0321,"volume":9698531,"delay":0,"ttmEps":2.248,"open":135.26,"prevYearClose":257.41,"prevWeekClose":136.1,"prevMonthClose":133.92,"prevQuarterClose":121.75,"fiveDayClose":135.77,"twentyDayClose":120.74,"sixtyDayClose":100.45,"dividendPayoutRate":1.9096682506550604,"dividendGrowthYears":5,"dividendGrowthRate":0.0117647058823529,"fiveYearAvgDividendRate":0.018048554743331537},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"COH.AU","amount":1.3,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-22","defaultRemindTime":1789948800000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-22","currency":"AUD","dateTimestamp":1789912800000,"payDate":"2026-10-14"},{"date":"2026-08-18","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-19","symbol":"COH.AU","amount":2.15,"announcedDate":"2026-02-12","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-20","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-13","payableDate":"2026-03-20","currency":"AUD","dateTimestamp":1773838800000,"payDate":"2026-04-13"},{"date":"2026-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770937200000,"name":null,"time":"","dateTimestamp":1770901200000,"actualEps":null},{"date":"2025-09-18","symbol":"COH.AU","amount":2.15,"announcedDate":"2025-08-15","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-19","defaultRemindTime":1758153600000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-13","payableDate":"2025-09-19","currency":"AUD","dateTimestamp":1758117600000,"payDate":"2025-10-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102102824","title":"Stock Track | Cochlear Ltd Plummets 33.74% Intraday on Earnings Guidance Cut and Middle East Sales Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1102102824","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102102824?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:04","pubTimestamp":1776816284,"startTime":"0","endTime":"0","summary":"Cochlear Ltd's stock plummeted 33.74% during intraday trading on Wednesday.The sharp decline followed the company's trading update which included a reduction of its FY26 underlying net profit...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["COH.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629826066","title":"Cochlear Ltd - Sees Second Half Sales Growth of 2-6% in Constant Currency","url":"https://stock-news.laohu8.com/highlight/detail?id=2629826066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629826066?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629668450","title":"Cochlear Ltd-Trading Update and Reduction to FY26 Earnings Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2629668450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629668450?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629663430","title":"Cochlear Ltd - There Is Heightened Uncertainty to Q4 Sales From Middle East Due to Conflict","url":"https://stock-news.laohu8.com/highlight/detail?id=2629663430","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629663430?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629346066","title":"Cochlear Ltd - Accelerating Plans to  ReShape Cost Base to Provide Increased Capacity to Invest in Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2629346066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629346066?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629106684","title":"Cochlear Ltd - Reduces Underlying Net Profit Guidance for FY26 to a$290-330 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2629106684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629106684?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629066562","title":"Cochlear Ltd - May Need to Consider Provisioning Some Receivables Due to M.east Conflict, up to a$10 Million Potential Net Profit Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2629066562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629066562?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629066344","title":"Cochlear Ltd - Since January, Trading Conditions for Cochlear Implants in Developed Markets Have Been Softer Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2629066344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629066344?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626403155","title":"Cochlear Says Bank of New York Mellon Becomes Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2626403155","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626403155?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:34","pubTimestamp":1775774071,"startTime":"0","endTime":"0","summary":"Cochlear  received notice that Bank of New York Mellon and its affiliated entities became a substantial holder of the company on Wednesday, according to a Friday filing with the Australian bourse.Bank of New York Mellon now owns 3.3 million shares in the company, representing 5% of the issued shares, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0130517989.USD","BK7007","COH.AU","BK4559","LU1571399168.USD","LU1201861249.SGD","LU1699723380.USD","BK4135","BK4588","LU0130102774.USD","LU0648001328.SGD","LU0980610538.SGD","BK4585","LU0477156953.USD","BK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625609917","title":"BUZZ-Australia's Cochlear enters recruiting phase for implant trial, Citi says","url":"https://stock-news.laohu8.com/highlight/detail?id=2625609917","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625609917?lang=en_us&edition=fundamental","pubTime":"2026-04-07 03:59","pubTimestamp":1775505560,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear enters recruiting phase for implant trial, Citi says ** Citi says Cochlear's COH.AX pivotal trial for totally implantable cochlear implant , moved into recruiting status, with center in Colorado coming online and others in the US in preparation** Estimated primary completion for trial remains October 2027, participants will be adults, Citi says** Citi says the development matters since part of a negative thesis on the stock is emergence of a competitive totally cochlear implant field without a clear view that COH will win** \"Longer term, for us to be more positive we need comfort around goal c.18% NPAT margins given the adult population\", Citi says** Citi views the adult population, from where growth must come, as more challenging due to higher effort required to bring patients into care and lower returns from fewer lifetime processor replacements** Seven of 15 analysts rate COH \"buy\" or higher, seven \"hold\" and one \"sell\"; median PT is A$245.75 – LSEG data** ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4N40P14F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135978748","title":"Three Dependable ASX Dividend Stocks for Passive Investment Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=1135978748","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135978748?lang=en_us&edition=fundamental","pubTime":"2026-03-31 11:10","pubTimestamp":1774926621,"startTime":"0","endTime":"0","summary":"For passive, long-term investment strategies, establishing a solid framework and asking the right questions is crucial. The goal is to identify ASX-listed dividend stocks that possess a strong...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Three Dependable ASX Dividend Stocks for Passive Investment Strategies","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOL.AU","BXB.AU","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110306669","title":"Achieving Millionaire Status Through Annual $5,000 Investments in ASX 200 Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1110306669","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110306669?lang=en_us&edition=fundamental","pubTime":"2026-03-30 11:50","pubTimestamp":1774842601,"startTime":"0","endTime":"0","summary":"Accumulating a million dollars often seems to demand a high income, a fortunate opportunity, or impeccable market timing.However, this is not always the case.Straightforward Investment...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GMG.AU","LU0128526141.USD","BK4600","CBA.AU","BK7501","BK4595","IE00B5TLWC47.USD","LU0170899867.USD","LU2177674079.SGD","LU0029874061.USD","TLS.AU","BK4023","RMD.AU","BK4137","BK4504","BK4567","BK4082","BK4588","BK4516","BK4167","BK4207","COH.AU","LU2008162690.USD","BK7007","BK4596","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622000381","title":"The ASX healthcare stocks with the biggest upside according to brokers","url":"https://stock-news.laohu8.com/highlight/detail?id=2622000381","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622000381?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:34","pubTimestamp":1774474480,"startTime":"0","endTime":"0","summary":"It's been well documented that ASX technology and healthcare stocks are trading at long-term lows.In fact, the S&P/ASX 200 Health Care Index  is down 32% in the last year, and 17% in 2026.For comparison, the S&P/ASX 200 Index  is down just 2% year to date, and remains up more than 6% over the last 12 months.Yesterday, I compiled a list of the tech stocks that have drawn the most attention from brokers recently.Now let's look at the healthcare stocks also drawing the best long-term targets from experts.It's important to remember these targets are not guaranteed to be met, however they can help act as a guide of which stocks may have fallen past fair value.Pro Medicus has been one of the most consistently covered healthcare stocks recently as it has continued to fall despite positive outlooks.At the time of writing, Pro Medicus shares are 45% year to date.This is despite the continued flow of new contract wins as the drivers of interest in its product remain firmly in place.However, brok","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/26/the-asx-healthcare-stocks-with-the-biggest-upside-according-to-brokers/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/26/the-asx-healthcare-stocks-with-the-biggest-upside-according-to-brokers/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["COH.AU","BK4588","BK7094","BK4550","BK4585","IXJ","PME.AU","VHT","XJO.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622049223","title":"Top brokers name 3 ASX shares to buy today","url":"https://stock-news.laohu8.com/highlight/detail?id=2622049223","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622049223?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:36","pubTimestamp":1774413370,"startTime":"0","endTime":"0","summary":"Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to a number of broker notes being released this week.Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:. Analysts at Bell Potter have retained their buy rating on this family safety technology company's shares with a trimmed price target of $37.75. According to the note, the broker has been looking ahead to Life360's quarterly update. It believes that after setting expectations relatively low for the first quarter, there is some chance of a small beat. However, it suspects this could be with its adjusted EBITDA margin rather than monthly active user growth. Outside this, the broker has lowered its valuation to reflect changes to its model, putting more emphasis on earnings and cash flow. Overall, the broker thinks recent share price weakness is an opportunity for investors to bu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/top-brokers-name-3-asx-shares-to-buy-today-25-march-2026/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/top-brokers-name-3-asx-shares-to-buy-today-25-march-2026/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["GMG.AU","BK7510","BK7016","BK7099","BK7155","360.AU","COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622401400","title":"Cochlear Bulls See No Near-Term Gene Therapy Impact -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2622401400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622401400?lang=en_us&edition=fundamental","pubTime":"2026-03-25 08:18","pubTimestamp":1774397880,"startTime":"0","endTime":"0","summary":"0018 GMT - Cochlear's bulls at UBS reassure investors that any impact on demand from gene therapies for congenital hearing loss remains many years away. Analysts at the investment bank acknowledge that therapy efficacy data is encouraging but stress that there will be no near-term material impact on the Australia-listed hearing-implant maker. For now, they tell clients in a note that they expect Cochlear's new Nexa implant to boost the company's market share. A recent sell-off in the stock is just an opportunity, they add. UBS keeps a buy rating and A$302.00 target price on the stock, which is up 1.5% at A$163.77. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622016321","title":"3 top blue-chip ASX 200 shares that look dirt cheap right now","url":"https://stock-news.laohu8.com/highlight/detail?id=2622016321","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622016321?lang=en_us&edition=fundamental","pubTime":"2026-03-25 05:29","pubTimestamp":1774387785,"startTime":"0","endTime":"0","summary":"A number of popular blue-chip ASX 200 shares recently hit 52-week lows or worse. While this is disappointing, it could have created a buying opportunity for patient investors. For example, listed belo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/3-top-blue-chip-asx-200-shares-that-look-dirt-cheap-right-now/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/3-top-blue-chip-asx-200-shares-that-look-dirt-cheap-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7505","COH.AU","BK7007","BK4585","BK7501","BK7097","CSL.AU","BK4588","BK7511","BK7508","TWE.AU","BK7067","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622090681","title":"I'm listening to Warren Buffett and loading up on cheap ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622090681","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622090681?lang=en_us&edition=fundamental","pubTime":"2026-03-25 03:00","pubTimestamp":1774378800,"startTime":"0","endTime":"0","summary":"Warren Buffett has always had a simple philosophy. Be greedy when others are fearful. Right now, there's definitely a lot of fear in the market. A number of high-quality ASX shares have been pushed do","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/im-listening-to-warren-buffett-and-loading-up-on-cheap-asx-shares-2/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/im-listening-to-warren-buffett-and-loading-up-on-cheap-asx-shares-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4534","IE00B1XK9C88.USD","IE00B775SV38.USD","BK7016","HK0000914660.USD","LU0048573561.USD","IE00BKDWB100.SGD","LU0648001328.SGD","LU1363072403.SGD","BRKW","LU0210528500.USD","BK7070","IE00BWXC8680.SGD","IE00BJLML261.HKD","LU2168564065.EUR","COH.AU","BRKC","LU0251131958.USD","LU2168564222.USD","LU1571399168.USD","LU0157215616.USD","LU2168563687.JPY","LU0980610538.SGD","BK7095","LU0787776722.HKD","ARR.AU","LU0154236417.USD","WTC.AU","ARR","IE00BK4W5L77.USD","BK4585","BK4588","LU0170899867.USD","LU0683600562.USD","LU0251142724.SGD","LU0640476718.USD","LU0053666078.USD","BK7007","FLT.AU","BRKD","BK7503","BRKU","BK4110","LU0256863811.USD","LU0149725797.USD","LU1914381329.SGD","SIG.AU","LU0417517546.SGD","BK7103"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620290420","title":"CSL and these ASX 200 stocks just hit 52-week lows: Should you buy the dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620290420","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620290420?lang=en_us&edition=fundamental","pubTime":"2026-03-19 11:03","pubTimestamp":1773889412,"startTime":"0","endTime":"0","summary":"It's been a tough session for the market. After a weak lead from Wall Street overnight, the ASX 200 is down around 1.55% at the time of writing on Thursday. That takes losses for March to roughly 7.5%, which is a meaningful pullback in such a short period.Whenever markets fall like this, quality stocks tend to get dragged down with everything else.That's exactly what we're seeing right now, with several well-known ASX 200 stocks hitting 52-week lows. The key question is: is this an opportunity for investors?CSL has been under pressure for a while now, and this latest selloff has pushed it to fresh lows.Sentiment has clearly turned cautious, but I don't think the long-term story has changed in any meaningful way.This is still one of Australia's highest-quality healthcare companies, with global scale, strong margins, and a long track record of innovation.Short-term earnings noise and investor concerns can move the share price around, but over time, businesses like CSL tend to reflect the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/19/csl-and-these-asx-200-stocks-just-hit-52-week-lows-should-you-buy-the-dip/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/19/csl-and-these-asx-200-stocks-just-hit-52-week-lows-should-you-buy-the-dip/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7511","BK7078","SG9999004303.SGD","LU1169589451.USD","BK7501","BK7067","BK7508","COH.AU","AMC.AU","BK7007","BK4086","CSL","LU0728928796.USD","LU1169590202.USD","SGXZ23171101.USD","ALL.AU","CSL.AU","BK7063"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620402124","title":"Why Cochlear and ResMed shares could be strong buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2620402124","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620402124?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:39","pubTimestamp":1773794353,"startTime":"0","endTime":"0","summary":"If you want exposure to the healthcare sector, then it could be worth hearing what Wilsons is saying. That's because the broker recently named the two popular ASX healthcare shares in this article as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/why-cochlear-and-resmed-shares-could-be-strong-buys/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/why-cochlear-and-resmed-shares-could-be-strong-buys/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2008162690.USD","BK4567","BK4082","BK4588","RMD.AU","BK7007","RMD","BK4548","BK4504","COH.AU","LU0170899867.USD","BK7501","IE00B5TLWC47.USD","LU2177674079.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620102874","title":"Cochlear Poised for Medium-Term Growth on Nexa Launch, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2620102874","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620102874?lang=en_us&edition=fundamental","pubTime":"2026-03-17 13:02","pubTimestamp":1773723720,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) is expected to see solid operational performance and increased market share from its new Nexa cochlear implant system, despite short-term currency headwinds, Jefferies said in a Tue","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":107,"code":"91000000","status":"200"}]}}